Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.

Kimmey BA, Rupprecht LE, Hayes MR, Schmidt HD.

Addict Biol. 2014 Jul;19(4):539-51. doi: 10.1111/adb.12014. Epub 2012 Dec 12.

2.

Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Hopkins TJ, Rupprecht LE, Hayes MR, Blendy JA, Schmidt HD.

Neuropsychopharmacology. 2012 Sep;37(10):2310-21. doi: 10.1038/npp.2012.83. Epub 2012 Jun 6.

3.

Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.

Lee AM, Arreola AC, Kimmey BA, Schmidt HD.

Behav Brain Res. 2014 Nov 1;274:168-75. doi: 10.1016/j.bbr.2014.08.016. Epub 2014 Aug 14.

4.

Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Liu X, Caggiula AR, Yee SK, Nobuta H, Sved AF, Pechnick RN, Poland RE.

Neuropsychopharmacology. 2007 Mar;32(3):710-8. Epub 2006 Jun 21.

5.

Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.

Bespalov AY, Dravolina OA, Sukhanov I, Zakharova E, Blokhina E, Zvartau E, Danysz W, van Heeke G, Markou A.

Neuropharmacology. 2005;49 Suppl 1:167-78.

PMID:
16023685
6.
7.

The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.

O'Connor EC, Parker D, Rollema H, Mead AN.

Psychopharmacology (Berl). 2010 Feb;208(3):365-76. doi: 10.1007/s00213-009-1739-5. Epub 2009 Dec 5.

PMID:
19967529
8.

Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).

Diergaarde L, de Vries W, Raasø H, Schoffelmeer AN, De Vries TJ.

Neuropharmacology. 2008 Oct;55(5):712-6. doi: 10.1016/j.neuropharm.2008.06.003. Epub 2008 Jun 7.

PMID:
18588903
9.

Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.

Di Clemente A, Franchi C, Orrù A, Arnt J, Cervo L.

Addict Biol. 2012 Mar;17(2):274-86. doi: 10.1111/j.1369-1600.2011.00319.x. Epub 2011 Apr 26.

PMID:
21521422
10.

Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.

Uslaner JM, Drott JT, Sharik SS, Theberge CR, Sur C, Zeng Z, Williams DL, Hutson PH.

Behav Brain Res. 2010 Feb 11;207(1):37-43. doi: 10.1016/j.bbr.2009.09.035. Epub 2009 Sep 30.

PMID:
19799936
11.

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.

Wouda JA, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D, Schoffelmeer AN, Pattij T, De Vries TJ.

Psychopharmacology (Berl). 2011 Jul;216(2):267-77. doi: 10.1007/s00213-011-2213-8. Epub 2011 Feb 18.

12.

Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats.

Vlachou S, Guery S, Froestl W, Banerjee D, Benedict J, Finn MG, Markou A.

Psychopharmacology (Berl). 2011 May;215(1):117-28. doi: 10.1007/s00213-010-2119-x. Epub 2010 Dec 22.

13.

The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake.

Gamaleddin I, Guranda M, Goldberg SR, Le Foll B.

Br J Pharmacol. 2011 Nov;164(6):1652-60. doi: 10.1111/j.1476-5381.2011.01440.x.

14.

Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.

Gamaleddin I, Wertheim C, Zhu AZ, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B.

Addict Biol. 2012 Jan;17(1):47-61. doi: 10.1111/j.1369-1600.2011.00314.x. Epub 2011 Apr 26.

PMID:
21521420
15.
16.

Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats.

Liu X, Caggiula AR, Yee SK, Nobuta H, Poland RE, Pechnick RN.

Psychopharmacology (Berl). 2006 Mar;184(3-4):417-25. Epub 2005 Sep 15.

17.

Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents.

Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P.

Eur Neuropsychopharmacol. 2009 Jul;19(7):487-98. doi: 10.1016/j.euroneuro.2009.01.007. Epub 2009 Feb 28.

PMID:
19250803
18.

Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers.

Ashare RL, Kimmey BA, Rupprecht LE, Bowers ME, Hayes MR, Schmidt HD.

Transl Psychiatry. 2016 Jan 19;6:e713. doi: 10.1038/tp.2015.209.

PMID:
26784967
19.

N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking.

Ramirez-Niño AM, D'Souza MS, Markou A.

Psychopharmacology (Berl). 2013 Jan;225(2):473-82. doi: 10.1007/s00213-012-2837-3. Epub 2012 Aug 19.

20.

Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.

Grasing K, Yang Y, He S.

Behav Pharmacol. 2011 Feb;22(1):58-70. doi: 10.1097/FBP.0b013e3283428cd8.

PMID:
22173266
Items per page

Supplemental Content

Write to the Help Desk